Contineum Therapeutics, Inc. ($CTNM)
Filing Information
| Accession Number | 0001437749-26-004122 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 13, 2026 |
| Document Date | Feb 11, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
1,200
Total Value
$6,804.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Class A Common Stock | โ | Feb 11, 2026 | Exercise/Conversion | 400 | $1.01 | $404.00 | 156,452 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Feb 11, 2026 | Sale | 400 | $16.00 | $6,400.00 | 156,052 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Feb 11, 2026 | Exercise/Conversion | 400 | $0.00 | $0.00 | 75,530 | Direct | โ | View Details |